Expression and Clinical Significance of miR-200c and miR-193a-3p in Invasive Pituitary Adenoma

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029244

Enrollment

Unknown

Registered

2020-01-19

Start date

2020-01-10

Completion date

Unknown

Last updated

2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Pituitary Adenoma

Interventions

invasive pituitary adenoma group vs. non-invasive pituitary adenoma group:N/A

Eligibility

Sex/Gender

All

Age

6 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Pituitary adenoma patients; 2. Surgical treatment; 3. Informed consent signed.

Exclusion criteria

Exclusion criteria: 1. Craniopharyngioma; 2. pituitary malignant tumor; 3. Rathke's cyst.

Design outcomes

Primary

Measure	Time frame
Gene expression level;	—

Countries

China

Contacts

Public ContactChuangxin Liao

Neurosurgery Unit of The East Division of the First Affiliated Hospital,Sun Yat-sen University

lcxsl@126.com+86 18902300826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026